Skip to main content
Log in

MPGN type I induced by granulocyte colony stimulating factor

  • Brief Report
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract 

We report a girl with severe congenital neutropenia who has received long-term granulocyte-colony stimulating factor (G-CSF) therapy and has developed macroscopic hematuria, proteinuria, and decreased renal function associated with biopsy-proven membranoproliferative glomerulonephritis (MPGN) type I. Temporary discontinuation of G-CSF therapy as well as the use of glycosylated G-CSF has resulted in improvement in renal manifestations. We postulate that the MPGN was G-CSF- induced. Long-term G-CSF therapy should be used with great caution and close surveillance of kidney function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 7 August 2001 / Revised: 2 January 2002 / Accepted: 4 January 2002

Rights and permissions

Reprints and permissions

About this article

Cite this article

Magen, D., Mandel, H., Berant, M. et al. MPGN type I induced by granulocyte colony stimulating factor. Pediatr Nephrol 17, 370–372 (2002). https://doi.org/10.1007/s00467-002-0847-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-002-0847-9

Navigation